Location History:
- Silver Spring, MD (US) (2011 - 2013)
- Highland, MD (US) (2019 - 2022)
Company Filing History:
Years Active: 2011-2022
Title: France Carrier: Innovator in Cancer Therapeutics
Introduction
France Carrier is a notable inventor based in Highland, MD (US), recognized for his contributions to the field of cancer therapeutics. With a total of 4 patents, he has made significant strides in developing innovative methods to inhibit protein synthesis in cancer cells.
Latest Patents
Carrier's latest patents focus on protein translation inhibitors and their applications in cancer treatment. One of his key inventions is a method that provides protein translation inhibitors and pharmaceutical compositions that bind to an RNA Recognition motif in heterogeneous ribonucleoprotein A18. This binding inhibits the interaction with mRNA transcripts, thereby reducing protein synthesis. Additionally, he has developed a method for treating cancer by administering these inhibitors, showcasing their potential in pharmaceutical applications.
Another significant patent involves therapeutics that target hnRNP A18, a crucial regulator of protein translation in cancer cells. This invention outlines a method for treating cancer by administering a therapeutically effective amount of a composition that decreases the level and/or activity of hnRNP A18. The composition may include a nucleic acid molecule that binds to a portion of the nucleotide sequence coding for hnRNP A18, providing a novel approach to cancer treatment.
Career Highlights
Carrier's work is primarily associated with the University System of Maryland, where he has been able to leverage academic resources to advance his research. His innovative approaches to cancer treatment have positioned him as a key figure in the field of medical research.
Collaborations
Throughout his career, Carrier has collaborated with esteemed colleagues, including Alexander D MacKerell, Jr and David J Weber. These partnerships have further enriched his research and contributed to the development of his patented technologies.
Conclusion
France Carrier's innovative work in developing protein translation inhibitors represents a significant advancement in cancer therapeutics. His contributions continue to pave the way for new treatment methodologies that could improve patient outcomes in the fight against cancer.